References
- Whitehead W E, Schuster M M. Irritable bowel syndrome: definition of the syndrome and relation to other disorders. Gastrointestinal disorders—behavioral and physiological basis for treatment, W E Whitehead, M M Schuster. Academic Press, San Diego, CA 1985; 155–77
- Manning A P, Thompson W G, Heaton K W, Morris A F. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653–4
- Drossman D A, Thompson W G. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992; 116: 1009–16
- Magni G. The use of antidepressants in the treatment of chronic pain. Review article. Drugs 1991; 42: 730–48
- Klein K B. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232–41
- Williams C. Antidepressants for chronic pain: More harm than help (Question). Pain 1990, Suppl 5: S284
- Pinder R M, Fink M. Mianserin. Mod Probl Pharmacopsychiatry 1982; 18: 70–101
- Van Dorth R M. Review of clinical studies with mianserin. Acta Psychiatr Scand 1983; 67(Suppl 302)72–80
- Carman J S, Ahdieh H, Wyatt-Knowles E, Warga E, Panagides J. A controlled study of maianserin in moderately to severely depressed outpatients. Psychopharmacol Bull 1991; 27: 135–9
- Lechin F, van der Dijs B. Opposite effects on human distal colon motility of two postulated alfa-2-antagonists (mianserin and chlorprothixene) and one alfa-2-agonist (clonidine). J Clin Pharmacol 1983; 23: 209–18
- Wilson J A, Read J RM, Boyd E JS, Wormsley K G. Inhibition of pentagastrin-stimulated and overnight gastric secretion by mianserin. Br J Clin Pharmacol 1983; 15: 329–33
- Wilson J A, Boyd E JS, Wormsley K G. Effects of some polycyclic drugs on gastric secretion and on the healing of duodunal ulcers. Acta Psychiatr Scand 1985; 72(suppl 320)S93–7
- Tanum L. Mianserin in chronic abdominal pain. Nord J Psychiatry 1993; 47: 351–4
- Guy W. Clinical global impressions. Early Clinical Drug Evaluation Unit (ECDEU-National Institute of Health), Bethesda, MD 1976; 212–22
- Perception of the values and benefits of research. A report by an international study group. Acta Psychiatr Scand 1986; 74(Suppl 331), May PRA, Smedby B, Wetterberg L, editors.
- Spitzer R L, Williams J BW, Gibbon M, First M B. Structured Clinical Interview for DSM-III-R—non-patient edition. American Psychiatric Press, Washington, DC 1990
- Snaith R P, Harrop F M, Newby D A, Teale C. Grade scores of the Montgomery-Åsberg Depression and the Clinical Anxiety Scales. Br J Psychiatry 1986; 148: 599–601
- Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70
- Leon A C, Shear M K, Portera L, Klerman G L. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol 1992; 27: 78–82
- Loldrup D, Langemark M, Hansen H J, Olesen J, Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. Psychopharmacology 1989; 99: 1–7
- Talley N J. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl 1829)47–60
- Klein K. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232–41
- Drossman D A, Funch-Jensen P, Janssens J, Talley N J, Thompson W G, Whitehead W E. Identification of subgroups of functional bowel disorders. Gastroenterol Int 1990; 3: 159–72
- Clinical evaluation of psychotropic drugs. Principles and guidelines, R F Prien, D S Robinson. Raven Press, New York 1994
- Skovlund E. Should the single-blind placebo responder exclusion phase be omitted from clinical trials. Nord J Psychiatry 1994; 48: 159–65
- Smith R C, Greenbaum D S, Vancouver J B, Henry R C, Reinhart M A, Greenbaum R B, et al. Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology 1991; 100: 591–5